Western Australian Consolidated Regulations Western Australian Consolidated Regulations (1) A medical
practitioner shall not write, issue or authorise a prescription or document
prescribing the use, sale or supply of a poison included in Schedule 8,
or supply a poison included in Schedule 8, for the treatment of a person,
other than a drug addict, for a period in excess of 60 days, or for
periods that in the aggregate over the preceding 12 months exceed
60 days, or for a course of treatment exceeding 60 days, unless he
has first obtained written authorisation to do so from the CEO.
(2) Where a medical
practitioner has written, issued or authorised a prescription or document
prescribing the use, sale or supply of a poison included in Schedule 8,
for the treatment of a person other than a drug addict, or supplied a poison
included in Schedule 8 for the treatment of a person, other than a drug
addict, for a period of 60 days, or for periods that in the aggregate
over the preceding 12 months exceed 60 days, or for a course of
treatment exceeding 60 days, the medical practitioner shall not
thereafter write, issue or authorise a prescription or document prescribing
the use, sale or supply of a poison included in Schedule 8 in relation to
that person or supply a poison included in Schedule 8 in relation to that
person unless —
(a) the
medical practitioner has first obtained written authorisation under this
regulation to do so from the CEO; or
(b) the
CEO has issued an authorisation under this regulation to do so in relation to
that person and the authorisation is current.
(3) Notwithstanding
any authorisation referred to in subregulation (1) or (2) a medical
practitioner shall not write, issue or authorise a prescription or document
prescribing the use, sale or supply of methadone or buprenorphine for the
treatment of a person or supply methadone or buprenorphine for the treatment
of a person except for a person suffering from intractable pain arising from a
condition of health other than addiction to drugs.
(4) In any
authorisation issued for the purposes of subregulation (1) or (2) given
with respect to a particular person the CEO may specify that any one or more
of the conditions and restrictions set out below apply,
namely —
(a) that
the prescription be issued by or the treatment be administered by a specified
medical practitioner;
(b) that
only a specified poison included in Schedule 8 be prescribed or used for
treatment;
(c) that
the type of the poison included in Schedule 8 specified be of the type
specified;
(d) that
the amount to be prescribed or used for treatment shall not exceed the amount
specified;
(e) that
the amount to be prescribed or used on any one day shall not exceed the amount
specified;
(f) that
the concentration to be prescribed shall not exceed the concentration
specified;
(g) that
the intervals between the issue of prescriptions or the administration of the
poison included in Schedule 8 shall be such as are specified;
(h) that
the prescription be supplied at the pharmacy specified;
(i)
that the amount dispensed on a single prescription not
exceed such amount as is specified;
(j) that
the amount that may be supplied on any one day shall not exceed such amount as
is specified.
(5) An authorisation
issued for the purposes of subregulation (1) or (2) is valid for
such period as is specified unless revoked by the CEO before the expiration of
that period.
(6) A medical
practitioner shall not write, issue or authorise a prescription or document
prescribing the use, sale or supply of a poison included in Schedule 8 or
supply a poison included in Schedule 8 otherwise than in accordance with
such conditions and restrictions as are specified.
(7) A pharmacist shall
not sell or supply a poison included in Schedule 8 otherwise than in
accordance with such conditions and restrictions as are specified pursuant to
this regulation.
(8) An authorisation
issued prior to 1 October 1980 is valid until revoked by the CEO or
until it expires whichever first occurs.
[Regulation 51F inserted in Gazette
3 Feb 1995 p. 342‑3; amended in Gazette
19 Mar 1996 p. 1230‑1; 11 Apr 1997
p. 1833; 16 Nov 2001 p. 5985; 15 Dec 2006
p. 5630 and 5631; 1 Oct 2010 p. 5079‑80.]
[Heading inserted in Gazette 12 Aug 2003
p. 3664; amended in Gazette 15 Sep 2009 p. 3573.]